For more information on EVERx, visit https://www.drinkeverx.com/
Learn more about Puration at www.purationinc.com
Puration recently announced executing a letter of intent ("LOI") for a spinoff transaction structured for PURA shareholders to receive one share of spinoff stock for every five shares of PURA stock that they hold. The spinoff is part of a Puration reorganization to concentrate on expanding the company’s cannabis infused beverage business that has grown 600% in the last year.
DALLAS , Sept. 25, 2018 /PRNewswire/ — Puration, Inc. (USOTC: PURA) ("PURA") today announced its entry into California with EVERx CBD Sports Water now available at Natural Herbal Pain Relief, a dispensary in San Jose, California at 2121 S 10th St, San Jose 95112. EVERx CBD Infused Sports Water has a clean and refreshing taste that comes with 10mg of CBD per 500ml bottle and an optimal alkaline pH level formulated with antioxidants and electrolytes The EVERx formula is backed by two patents. Natural Herbal Pain Relief is a medical cannabis collective and wellness center billed as San Jose’s most compassionate wellness center.
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Brian Shibley ,
Tel : +1(800) 861-1350
On the provider side, Generex’s management services remove administrative burdens in multiple provider settings, including private practice and hospital, allowing doctors to devote more time to patient care.
About Generex Biotechnology Corporation
“We are especially excited about Puration’s patented extraction technology that enables us to explicitly define and characterize the CBD and cannabinoid content of hemp extracts to develop proprietary, patented formulations for NuGenerex,” said Jason Terrell, MD, Chief Medical and Scientific Officer of Generex. “Through NuGenerex Distribution Solutions, we have the consumer connections, technology, and HIPAA compliant systems that will enable us to compile real world evidence on the safety and effectiveness of our NuGenerex CBD products for health maintenance in a variety of chronic conditions.”
“In anticipation of the agreement announced today with Generex, we have already been working on new CBD extracts to support Generex’s therapeutic objectives,” said Brian Shibley, CEO of Puration, Inc. “With our US Cannabis Health partners, we are confident in the potential of the new extracts to meet and exceed Generex’s expectations. We are honored to be engaged by a company the caliber of Generex on this exciting project.”
Cautionary Note Regarding Forward-Looking Statements
Revenue from the Company’s subsidiaries will support clinical advancement of its wholly owned therapeutic products with a focus in immunotherapeutics based on stimulating critical members of the immune response, known as T helper cells, and its proprietary buccal administration of insulin.
Generex is a strategic, diversified healthcare holdings company with offerings in a variety of services, diagnostics, Health devices, and pharmaceutical development.